|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits in banks | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Available for sale | ||||||||||||||||||||
| Held to maturity, net of allowance for credit losses of $38 and $41 at June 30, 2026, and December 31, 2025, respectively (fair value of $9,074 and $9,607 at June 30, 2026, and December 31, 2025, respectively) | ||||||||||||||||||||
| Securities carried at fair value through income | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Non-marketable equity securities held in other financial institutions | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $98,188 and $96,782 at June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Mortgage servicing rights (“MSR”) | ||||||||||||||||||||
| Cash surrender value of bank-owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Home Loan Bank (“FHLB”) advances, repurchase agreements and other borrowings | ||||||||||||||||||||
| Subordinated indebtedness, net | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies - See Note 19 — Commitments and Contingencies | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value, 2,000,000 shares authorized | ||||||||||||||||||||
| Common stock ($5.00 par value; 50,000,000 shares authorized; 30,850,397 and 30,952,428 shares issued at June 30, 2026, and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid‑in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...
